Jason Wild, Angel Investor

Jason Wild is President and Portfolio Manager of JW Asset Management, a role he has held since 1998. Over nearly three decades, he has built the firm into a respected investment platform with a focus on healthcare and emerging growth sectors. He also served as Chairman of the Board at Arbor Pharmaceuticals and as a board member at Vensun Pharmaceuticals, underscoring his deep expertise in the pharmaceutical industry. His career reflects a blend of long‑term portfolio management and strategic leadership, guiding companies through growth and transformation. At Arbor, he oversaw expansion into specialty pharmaceuticals, while his board work at Vensun highlighted his commitment to advancing healthcare innovation. As an investor, Jason has backed ventures across healthcare and technology. His recent investments include TerrAscend in 2025 and InnovationForce, a pre‑seed investment in 2024. These deals reflect his continued focus on supporting companies positioned to drive innovation and scale.